February 23, 2018 + Jessica Di Palo
5 Min read
MTIP Expands TytoCare Funding Round to $25M, Joining an International Syndicate for the telehealth Start-up.
MTIP joins a large list of strategic and financial investors to expand a funding round for TytoCare, an Israel-based digital health company with breakthrough technology for conducting comprehensive examinations and telehealth visits, to $28M. Additional investors include Ping An Global Voyager Fund, Cambia Health Solutions, Walgreens, Orbimed, Fosun Pharma, LionBird and Qure. As the sole European based investor, MTIP is working with TytoCare to help them expand in the European region.
Following its FDA clearance in late 2016, and the launch of its products in the United States in early 2017, TytoCare has gained significant traction with major US health systems, telehealth companies, large private practices and employers. TytoCare will use the additional funding to continue its expansion in the US market and enhance its product offerings and smart data analytics to empower both clinicians and consumers doing telehealth. The funds will also help TytoCare fulfil the demand for its products outside the US and penetrate both the Asian and European markets.
“MTIP has played and will continue to play a vital role in opening doors and creating potential partnerships throughout Europe,” said Dedi Gilad, Co-Founder and CEO of TytoCare. “Building on the success and excitement for TytoCare in the US, we are pleased to be partnering with such a knowledgeable digital health investor whose unique position will help us further transform telehealth and reach more homes around the globe, especially in Europe.”
“TytoCare has an exceptional telehealth solution that will revolutionize how patients receive primary care,” said Dr Christoph Kausch Founding Partner and CEO of MTIP. “The quality of the management team is exceptional and we look forward to taking part in TytoCare’s success.”
Bruce Meadows, the Fund’s Senior Investment Director, added that “TytoCare fits perfectly into MTIP’s digital health strategy. Their connected suite of tools is at the intersection of telehealth and medical devices. Their ability to generate clinical quality data combined with machine learning produces better outcomes for patients and cost efficiency for healthcare systems.”
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
New MTIP investment in Oviva
New investment in Oviva
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
MTIP Healthcare Clinic 2019
Healthcare clinic 2019
New MTIP investment in Cynerio
New investment in Cynerio
MTIP invests in Lumeon Ltd.
New investment in Lumeon
Magenverkleinerung mit der Handnähmaschine
Nitinotes news paper article
New MTIP investment in Quanta Dialysis Technologies
New investment in Quanta
MTIP’s Healthcare Clinic 2018
Healthcare Clinic 2018
Interview with Christoph Kausch in biotechandmoney
New MTIP investment – Nitinotes Series A Round
New investment in Nitinotes
New investment in an Israeli based digital health company TytoCare
New investment in TytoCare
MTIP joins United Nations-supported Principles for Responsible Investments
MTIP signs Principles for Responsible Investments
MTIP invests in Blueprint Genetics
new investment in Blueprint Genetics